C90.02
C90.02: Multiple myeloma in relapse
Billable / specific codeICD-10-CM
C90.02 is a billable, specific ICD-10-CM code for multiple myeloma in relapse. It is valid for submission on a claim.
Check C90.02 with the rest of the claim: free scrubberExcludes1 inherited from the categories above C90.02
A category’s note binds every code beneath it.
Risk adjustment
C90.02 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 19 Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers1.798 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C90.02 is named in 56 Medicare coverage policies: 56 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52370Billing and Coding: Bevacizumab and biosimilars
- A52399Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
Code history
Unchanged in every release from FY2024 to FY2027.